Locus-specific loss of heterozygosity (LOH) (i.e. absence of wild-type BRCA1 copy) is observed in BRCA1 breast cancers [59]; however, the impact of LOH on BRCA1 variants are still under investigation [60]. Here, BRCA1 is linked to breast cancer.